Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Central Govt bans Nimesulide, Levocetrizine combination

      Central Govt bans Nimesulide, Levocetrizine combination

      Ruby Khatun Khatun15 Jun 2017 11:32 AM IST
      Through a gazette notification, the Central government has recently banned the fixed dose combination of Nimesulide + Levocetrizine announcing that...
      Diabetes Digital Therapeutics Enters South Asia as Mumbai-based Wellthy Therapeutics Publishes Successful Clinical Outcomes

      Diabetes Digital Therapeutics Enters South Asia as Mumbai-based Wellthy Therapeutics Publishes Successful Clinical Outcomes

      Ruby Khatun Khatun15 Jun 2017 10:52 AM IST
      Wellthy Therapeutics announced results from a pilot designed to evaluate the feasibility and scalability of an artificial intelligence-led lifestyle...
      Pfizer, Roche and Aspen face South African probe into cancer drug prices

      Pfizer, Roche and Aspen face South African probe into cancer drug prices

      Ruby Khatun Khatun15 Jun 2017 10:52 AM IST
      PRETORIA: South Africa's competition watchdog has launched an investigation into three drug companies accused of over-charging for cancer medicines,...
      Gelatin or cellulose capsules: Health Ministry invites comments

      Gelatin or cellulose capsules: Health Ministry invites comments

      Ruby Khatun Khatun15 Jun 2017 10:45 AM IST
      Taking a call, on whether consumers should go on consuming gelatin capsules, derived from animal sources, or replace them with plant-based cellulose...
      Sanofi, Regenerons Praluent Cuts Bad Cholesterol in Studies

      Sanofi, Regeneron's Praluent Cuts Bad Cholesterol in Studies

      Ruby Khatun Khatun15 Jun 2017 9:45 AM IST
      Paris, France and Tarrytown, N.Y.: Sanofi and Regeneron Pharmaceuticals, Inc. announced positive results from two Phase 3b/4 ODYSSEY-DM trials in...
      Boston Scientific launches next generation asthma therapy

      Boston Scientific launches next generation asthma therapy

      Ruby Khatun Khatun15 Jun 2017 9:45 AM IST
      Mumbai: Boston Scientific India announced that it has launched the next generation asthma therapy in the country to address the needs of patients with...
      Board of Kovai Medical Center and Hospital recommends final dividend

      Board of Kovai Medical Center and Hospital recommends final dividend

      Ruby Khatun Khatun15 Jun 2017 9:45 AM IST
      The board Of Kovai Medical Center and Hospital have recommended the final dividend of Rs 2.5 per equity Share.Kovai Medical Center and Hospital Ltd...
      Zydus Cadila gets USFDA nod for ezetimibe tablets

      Zydus Cadila gets USFDA nod for ezetimibe tablets

      Ruby Khatun Khatun14 Jun 2017 11:52 AM IST
      New Delhi: Drug firm Zydus Cadila said it has received approval from the US health regulator to market ezetimibe tablets used to treat high...
      Aster DM Healthcare eyes Saudi market despite past payment delays

      Aster DM Healthcare eyes Saudi market despite past payment delays

      Ruby Khatun Khatun14 Jun 2017 11:45 AM IST
      DUBAI: Dubai-based Aster DM Healthcare is looking at acquisition opportunities in Saudi Arabia, its managing director told Reuters in an...
      Johnson & Johnson diabetes drug, Invokana shows heart benefit in large safety study

      Johnson & Johnson diabetes drug, Invokana shows heart benefit in large safety study

      Ruby Khatun Khatun14 Jun 2017 11:44 AM IST
      Johnson & Johnson's type 2 diabetes drug Invokana significantly reduced the risk of serious heart problems in patients with established heart...
      Prices of many essential drugs to rise up to 2.29 percent post-GST

      Prices of many essential drugs to rise up to 2.29 percent post-GST

      Ruby Khatun Khatun14 Jun 2017 11:44 AM IST
      New Delhi: Prices of a majority of essential drugs will increase by up to 2.29 per cent when the Goods and Services Tax regime kicks in from next...
      Suven Life Sciences gets patents for anti-neuro degeneration molecule

      Suven Life Sciences gets patents for anti-neuro degeneration molecule

      Ruby Khatun Khatun14 Jun 2017 11:43 AM IST
      New Delhi: Drug firm Suven Life Sciences has received one product patent each from Australia and the US for its molecule to be used in the treatment...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok